Carvedilol
Product Images NDC 67296-1497

Product Visual Gallery

This gallery contains 21 technical images submitted to the FDA as part of the official labeling for Carvedilol (NDC 67296-1497). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carvedilol Tablets Usp, 12.5 mg (NDC 72888-036-00)

Carvedilol Tablets, USP 12.5 mg label showing a package size of 1000 tablets. The label includes storage instructions to keep below 30°C and protect from moisture. It identifies Advagen Pharma Limited as the distributor and Rubicon Research Private Limited as the manufacturer. The label features the proprietary name Carvedilol prominently along with NDC 72888-036-00.*

FDA Label Image

Carvedilol Tablets Usp, 12.5 mg (NDC 72888-036-01)

Label for Carvedilol Tablets USP 12.5 mg, containing 100 tablets. The label includes storage instructions, dosage information, and a warning about the seal under the cap. Distributed by Advagen Pharma Limited in New Jersey, USA, and manufactured by Rubicon Research Private Limited in India. The label also features a barcode and an overprinting area.*

FDA Label Image

Carvedilol Tablets Usp, 12.5 mg (NDC 72888-036-30)

Carvedilol Tablets, USP 12.5 mg label showing product information including dosage strength, quantity of 30 tablets, and storage instructions. The label includes barcode, NDC 72888-036-30, and distributor Advagen Pharma Limited, with manufacturer Rubicon Research Private Limited, India. The label warns not to accept if seal under the cap is broken and advises dispensing in a tight, light-resistant container.*

FDA Label Image

Carvedilol Tablets Usp, 12.5 mg (NDC 72888-036-05)

Label for Carvedilol Tablets, USP 12.5 mg, containing 500 tablets. Distributed by Advagen Pharma Limited and manufactured by Rubicon Research Private Limited in India. The label includes storage instructions and cautions regarding the tablet seal and container. NDC code shown is 72888-036-05.*

FDA Label Image

Carvedilol Tablets Usp, 25 mg (NDC 72888-037-00)

Carvedilol Tablets, USP 25 mg label showing packaging for 1000 tablets. The label includes storage instructions, distributor Advagen Pharma Limited in Plainsboro, NJ, and manufacturer Rubicon Research Private Limited in India. The label also has NDC 72888-037-00 and a barcode.*

FDA Label Image

Carvedilol Tablets Usp, 25 mg (NDC 72888-037-01)

The packaging label for CARVEDILOL Tablets USP shows 25 mg strength in a white container label with blue highlights. It indicates 100 tablets per container, Rx only, and includes storage and usage warnings. The label lists Advagen Pharma Limited as distributor and Rubicon Research Private Limited as manufacturer, with barcodes and product codes visible.*

FDA Label Image

Carvedilol Tablets Usp, 25 mg (NDC 72888-037-30)

Carvedilol Tablets, USP 25 mg label showing a package of 30 tablets. The label includes storage instructions, dosage advisory, and warnings about seal integrity. The label states it is Rx only and lists Advagen Pharma Limited as distributor and Rubicon Research Private Limited as manufacturer. NDC 72888-037-30 is printed on the label.*

FDA Label Image

Carvedilol Tablets Usp, 25 mg (NDC 72888-037-05)

Carvedilol Tablets, USP 25 mg label showing a bottle label with 500 tablets count. The label includes storage instructions below 30°C and a warning not to accept if the seal under the cap is missing or broken. Distributed by Advagen Pharma Limited and manufactured by Rubicon Research Private Limited in India. The label features a blue box highlighting the 25 mg strength and includes NDC 72888-037-05.*

FDA Label Image

Carvedilol Tablets Usp, 3.125 mg (NDC 72888-034-00)

Carvedilol Tablets USP 3.125 mg label shows a 1000-tablet bottle with distribution by Advagen Pharma Limited, Plainsboro, NJ, and manufacturing by Rubicon Research Private Limited, India. The label includes storage instructions, a caution not to accept if the cap seal is broken, and the NDC 72888-034-00. Marked Rx Only.*

FDA Label Image

Carvedilol Tablets Usp, 3.125 mg (NDC 72888-034-01)

Label for Carvedilol Tablets USP, 3.125 mg strength, showing packaging for 100 tablets. The label includes storage instructions, barcode, and distributor/manufacturer details: Advagen Pharma Limited and Rubicon Research Private Limited. The label highlights the dosage strength in yellow and notes the product is Rx only.*

FDA Label Image

Carvedilol Tablets Usp, 3.125 mg (NDC 72888-034-30)

Carvedilol Tablets, USP 3.125 mg label with 30 tablets count. The label shows dosage strength, prescription status (Rx only), storage instructions to protect from moisture and store below 30°C. It includes distributor Advagen Pharma Limited in NJ, manufacturer Rubicon Research Private Limited in India, and a barcode with NDC 72888-034-30. The label also cautions not to accept if seal is broken and references accompanying prescribing information.*

FDA Label Image

Carvedilol Tablets Usp, 3.125 mg (NDC 72888-034-05)

Carvedilol Tablets, USP 3.125 mg label showing a package of 500 tablets. The label includes storage instructions, a barcode, NDC 72888-034-05, and distributor and manufacturer information from Advagen Pharma Limited and Rubicon Research Private Limited.*

FDA Label Image

Carvedilol Tablets Usp, 6.25 mg (NDC 72888-035-00)

Carvedilol Tablets USP 6.25 mg label displaying 1,000 tablets in the package. The label includes storage instructions, sealing warnings, and directs to accompanying prescribing information for dosage details. Distributed by Advagen Pharma Limited, Plainsboro, NJ, and manufactured by Rubicon Research Private Limited, India. Includes NDC code 72888-035-00 and barcode.*

FDA Label Image

Carvedilol Tablets Usp, 6.25 mg (NDC 72888-035-01)

Carvedilol Tablets, USP 6.25 mg label showing 100 tablets in the package. The label includes storage instructions, dosage guidance to see prescribing information, and a barcode. Distributed by Advagen Pharma Limited, manufactured by Rubicon Research Private Limited in India. The NDC displayed is 72888-035-01.*

FDA Label Image

Carvedilol Tablets Usp, 6.25 mg (NDC 72888-035-30)

The label for Carvedilol Tablets, USP 6.25 mg shows a white rectangular panel with black text. It instructs storage below 30°C and cautions not to accept if the seal under the cap is broken. The label indicates 30 tablets per container, Rx only, and states dosage information is provided separately. Distributed by Advagen Pharma Limited and manufactured by Rubicon Research Private Limited India. The product NDC on the label is 72888-035-30.*

FDA Label Image

Carvedilol Tablets Usp, 6.25 mg (NDC 72888-035-05)

Label for Carvedilol Tablets USP 6.25 mg, containing 500 tablets. The label includes storage instructions, a warning about the seal under the cap, and advises consulting prescribing information for dosage. Distributed by Advagen Pharma Limited and manufactured by Rubicon Research Private Limited. Includes barcodes and revision details (Rev.02, 07/21).*

FDA Label Image

Figure 1. Survival Analysis For Copernicus (intent-to-treat) (Carvedilol Tab Usp Figure1)

A line graph comparing mortality percentages over 21 months between Carvedilol and placebo groups. The x-axis represents time in months, and the y-axis shows % mortality. The graph indicates lower mortality in the Carvedilol group compared to placebo, with a p-value of 0.0014 shown on the chart.*

FDA Label Image

Figure 2. Effects On Mortality For Subgroups In Copernicus (Carvedilol Tab Usp Figure2)

A forest plot illustrating hazard ratios for various patient subgroups, including gender, age, race, diabetic status, ischemic status, heart rate, systolic blood pressure (SBP), and use of spironolactone, with a vertical line at 1.0 as reference. Each group's hazard ratio is represented by a dot with horizontal confidence intervals.*

FDA Label Image

Figure 3. Survival Analysis For Capricorn (intent-to-treat) (Carvedilol Tab Usp Figure3)

A line graph illustrating % mortality over 24 months comparing Carvedilol and placebo groups. The y-axis represents percent mortality, and the x-axis shows time in months. The graph shows lower mortality in the Carvedilol group compared to placebo, with a p-value of 0.03 indicating statistical significance.*

FDA Label Image

Figure 4. Effects On Mortality For Subgroups In Capricorn (Carvedilol Tab Usp Figure4)

A forest plot illustrating hazard ratios for various subgroups in a study. The horizontal axis represents hazard ratios ranging from 0.4 to 1.3. Each subgroup (e.g., age, gender, prior beta-blocker use, Killip class, diabetes status) is listed on the vertical axis with corresponding points and confidence intervals represented as horizontal lines. Two separate panels compare different conditions such as prior heart failure, diuretic use, angina, hypertension, and blood pressure levels.*

FDA Label Image

Carvedilol Chemical Structure (Carvedilol Tab Usp Structure)

Chemical structure diagram of the active ingredient Carvedilol, showing its molecular framework including fused rings and functional groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.